Eurofins Cerep

Equities

ALECR

FR0013256518

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 10:30:01 2024-04-15 am EDT			5-day change	1st Jan Change
21,800 ^EUR	-0.91%		0.00%	-12.80%

2023	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2022	Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022	CI

Eurofins Cerep : annonce ses résultats 2022

April 12, 2023 at 03:30 pm EDT

Eurofins Cerep annonce ses résultats 2022

12 Apr 2023 21:17 CEST

Issuer

EUROFINS CEREP

eurofins-cerepannonce-ses-resultats-20223.pdf

Source

EUROFINS CEREP

Provider

Euronext

Company Name

EUROFINS CEREP

ISIN

FR0013256518

Symbol

ALECR

Market

Euronext Growth

Attachments

Original Link
Original Document
Permalink

Disclaimer

Eurofins Cerep SA published this content on 12 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 April 2023 19:29:07 UTC.

Latest news about Eurofins Cerep

Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-29	CI
Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-29	CI
Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-11	CI
Global markets live: Daimler, GSK, Mattel	21-04-16
Eurofins Cerep : Launches PCR COVID-19 Self-Test In Germany, Spain	20-12-23	MT
Eurofins-Cerep Sa Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-24	CI
Eurofins Cerep SA acquired KVI-Plusz.	18-07-29	CI
Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, completed the acquisition of a majority stake in Bioaccess S.A.	15-08-03	CI
Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, agreed to acquire majority stake in Bioaccess S.A. for €225 million.	15-06-17	CI
Eurofins-Panlabs, Inc. completed the acquisition of Cerep Inc. from Cerep SA.	13-12-30	CI
Eurofins-Panlabs, Inc. agreed to acquire Cerep Inc. from Cerep SA for $0.27 million.	13-12-12	CI
Eurofins Discovery Services Lux Holding completed the acquisition of 8.48% stake in Cerep SA from Thierry Jean.	13-03-31	CI
Eurofins Scientific SA completed the acquisition of 75.13% stake in Cerep SA for €18.9 million.	13-02-27	CI
Eurofins Scientific SA made an offer to acquire remaining 91.52% stake in Cerep SA for €23.1 million.	12-12-20	CI
Eurofins Discovery Services Lux Holding agreed to acquire 8.48% stake in Cerep SA from Thierry Jean for €2.1 million.	12-12-20	CI

Chart Eurofins Cerep

Duration

Period

More charts

Company Profile

Eurofins Cerep (formerly Eurofins-Cerep) specializes in the pre-clinical research of drugs for the pharmaceutical industry. Exports account for 97.9% of net sales.

Sector

Biotechnology & Medical Research

Calendar

2024-05-22 - Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
EUROFINS CEREP	-12.80%	117M
IQVIA HOLDINGS INC.	+1.77%	42.75B
LONZA GROUP AG	+47.70%	41.61B
MODERNA, INC.	+12.24%	41.34B
CELLTRION, INC.	-8.83%	26.59B
ICON PUBLIC LIMITED COMPANY	+7.44%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-23.01%	18.12B
MEDPACE HOLDINGS, INC.	+30.56%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.82%	11.76B
UNITED THERAPEUTICS CORPORATION	+8.35%	11B

Other Biotechnology & Medical Research